Profile data is unavailable for this security.
About the company
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
- Revenue in USD (TTM)1.64bn
- Net income in USD-516.47m
- Incorporated1989
- Employees4.43k
- LocationIntegra Lifesciences Holdings Corp1100 Campus RoadPRINCETON 08540United StatesUSA
- Phone+1 (609) 275-0500
- Fax+1 (609) 750-4277
- Websitehttps://www.integralife.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytek Biosciences Inc | 196.83m | -12.82m | 575.90m | 692.00 | -- | 1.51 | -- | 2.93 | -0.1011 | -0.1011 | 1.54 | 2.96 | 0.3992 | 1.86 | 3.60 | 303,746.90 | -2.60 | 0.3407 | -3.02 | 0.3811 | 53.46 | 58.12 | -6.51 | 0.8678 | 4.48 | -- | 0.0213 | -- | 3.85 | 28.20 | 50.44 | -- | 30.83 | -- |
| Embecta Corp | 1.08bn | 139.50m | 607.60m | 1.85k | 4.34 | -- | 3.36 | 0.5627 | 2.37 | 2.37 | 18.31 | -10.35 | 0.9757 | 2.27 | 6.35 | 583,621.60 | 12.61 | 16.69 | 16.60 | 22.65 | 63.17 | 66.74 | 12.92 | 15.71 | 1.87 | 3.18 | 1.79 | 13.07 | -3.80 | -0.1033 | 21.84 | -25.93 | -26.03 | -- |
| Anteris Technologies Global Corp | 2.14m | -84.32m | 632.98m | 136.00 | -- | 63.48 | -- | 295.91 | -2.34 | -2.34 | 0.0594 | 0.1025 | 0.1065 | 1.53 | 11.88 | 15,728.75 | -420.16 | -- | -1,527.00 | -- | 67.94 | -- | -3,945.70 | -- | 0.8032 | -- | 0.046 | -- | -1.16 | -- | -65.77 | -- | -- | -- |
| Avanos Medical Inc | 701.20m | -72.90m | 655.70m | 2.29k | -- | 0.8417 | -- | 0.9351 | -1.58 | -1.58 | 15.10 | 16.75 | 0.6295 | 2.42 | 6.06 | 306,602.50 | -6.54 | -5.81 | -7.69 | -6.58 | 50.47 | 53.66 | -10.40 | -12.67 | 1.26 | 11.11 | 0.1144 | -- | 1.95 | -0.3835 | 81.13 | -- | 9.36 | -- |
| Tactile Systems Technology Inc | 329.52m | 19.09m | 657.24m | 1.09k | 35.09 | 3.00 | 25.54 | 1.99 | 0.8347 | 0.8347 | 14.21 | 9.76 | 1.15 | 9.92 | 7.42 | 303,427.30 | 6.67 | 2.68 | 7.79 | 3.21 | 50.79 | 49.70 | 5.79 | 2.58 | 3.69 | -- | 0.00 | 0.00 | 12.47 | 11.98 | 12.54 | -- | 2.04 | -- |
| Alpha Tau Medical Ltd | 0.00 | -39.97m | 661.65m | 125.00 | -- | 8.53 | -- | -- | -0.5212 | -0.5212 | 0.00 | 0.9099 | 0.00 | -- | -- | 0.00 | -40.90 | -34.28 | -44.43 | -36.47 | -- | -- | -- | -- | -- | -- | 0.0735 | -- | -- | -- | -8.89 | -- | 11.60 | -- |
| SI-Bone Inc | 200.93m | -18.90m | 685.45m | 376.00 | -- | 3.82 | -- | 3.41 | -0.4418 | -0.4418 | 4.68 | 4.07 | 0.8568 | 1.35 | 7.00 | 534,375.00 | -8.06 | -20.29 | -9.08 | -22.64 | 79.57 | 81.28 | -9.41 | -29.99 | 7.21 | -- | 0.1669 | -- | 20.19 | 22.32 | 38.85 | -- | 26.86 | -- |
| CeriBell Inc | 89.06m | -53.41m | 702.76m | 327.00 | -- | 4.51 | -- | 7.89 | -1.46 | -1.46 | 2.44 | 4.14 | 0.4229 | 1.52 | 5.94 | 272,363.90 | -25.36 | -- | -27.46 | -- | 87.89 | -- | -59.97 | -- | 9.35 | -30.90 | 0.1131 | -- | 36.09 | -- | -32.03 | -- | -- | -- |
| Bioventus Inc | 563.83m | 7.82m | 726.66m | 950.00 | 78.16 | 4.37 | 12.67 | 1.29 | 0.1123 | 0.1123 | 8.39 | 2.01 | 0.7666 | 1.95 | 4.47 | 606,267.80 | 1.31 | -6.29 | 1.89 | -8.49 | 67.76 | 67.40 | 1.71 | -12.07 | 1.14 | 1.73 | 0.616 | -- | 11.89 | 11.00 | 65.33 | -- | -15.55 | -- |
| Inmode Ltd | 370.50m | 93.83m | 871.18m | 660.00 | 9.53 | 1.28 | 9.22 | 2.35 | 1.44 | 1.44 | 5.67 | 10.78 | 0.4774 | 1.19 | 9.28 | 561,356.10 | 12.09 | 24.21 | 13.30 | 26.82 | 78.54 | 82.36 | 25.33 | 38.64 | 8.83 | -- | 0.00 | 0.00 | -6.16 | 12.44 | -48.24 | 4.57 | 15.99 | -- |
| Castle Biosciences Inc | 343.53m | -12.24m | 879.15m | 761.00 | -- | 1.85 | 28.80 | 2.56 | -0.4533 | -0.4533 | 11.67 | 16.02 | 0.6377 | 9.05 | 6.89 | 451,419.20 | -2.27 | -6.95 | -2.50 | -7.52 | 79.94 | 80.76 | -3.56 | -17.49 | 6.31 | -- | 0.0218 | -- | 51.09 | 44.97 | 131.75 | 43.57 | 97.74 | -- |
| Integra Lifesciences Holdings Corp | 1.64bn | -516.47m | 886.93m | 4.43k | -- | 0.8494 | -- | 0.5424 | -6.74 | -6.74 | 21.33 | 13.40 | 0.4281 | 1.54 | 5.93 | 369,379.90 | -13.52 | -0.5552 | -16.50 | -0.632 | 56.62 | 61.01 | -31.58 | -1.34 | 1.46 | 2.75 | 0.6401 | -- | 1.53 | 3.57 | -7,337.70 | -- | 8.40 | -- |
| Butterfly Network Inc | 88.45m | -79.87m | 961.69m | 190.00 | -- | 4.70 | -- | 10.87 | -0.3347 | -0.3347 | 0.3729 | 0.8071 | 0.3186 | 0.7409 | 3.93 | 465,515.80 | -28.77 | -- | -34.57 | -- | 43.24 | -- | -90.31 | -190.03 | 3.56 | -- | 0.00 | -- | 24.52 | -- | 45.78 | -- | -- | -- |
| STAAR Surgical Co | 230.59m | -96.37m | 989.86m | 1.16k | -- | 2.78 | -- | 4.29 | -1.96 | -1.96 | 4.64 | 7.17 | 0.464 | 1.29 | 2.80 | 199,300.80 | -19.39 | 3.81 | -22.26 | 4.42 | 73.87 | 77.03 | -41.79 | 5.42 | 4.35 | -- | 0.00 | 0.00 | -2.64 | 15.89 | -194.66 | -- | 18.11 | -- |
| BioLife Solutions Inc | 88.83m | -13.99m | 1.17bn | 159.00 | -- | 3.28 | -- | 13.16 | -0.2922 | -0.061 | 1.87 | 7.37 | 0.2296 | 0.8875 | 6.18 | 558,698.10 | -3.62 | -1.92 | -3.92 | -2.10 | 70.02 | 52.54 | -15.75 | -9.06 | 3.64 | -- | 0.0207 | -- | 8.44 | 24.62 | 38.27 | -- | 19.15 | -- |
Data as of Mar 02 2026. Currency figures normalised to Integra Lifesciences Holdings Corp's reporting currency: US Dollar USD
56.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 9.40m | 12.07% |
| Rubric Capital Management LPas of 31 Dec 2025 | 7.75m | 9.96% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 6.60m | 8.47% |
| Fuller & Thaler Asset Management, Inc.as of 31 Dec 2025 | 3.64m | 4.67% |
| Invesco Advisers, Inc.as of 31 Dec 2025 | 3.13m | 4.02% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 2.92m | 3.75% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 2.81m | 3.61% |
| Boston Management & Researchas of 31 Dec 2025 | 2.74m | 3.52% |
| Paradigm Capital Management, Inc.as of 31 Dec 2025 | 2.66m | 3.42% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2025 | 2.08m | 2.67% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
